10 20 30 40 50 60 70 80 1GCW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXYGEN STORAGE/TRANSPORT 08-AUG-00 1GCW
TITLE CO FORM HEMOGLOBIN FROM MUSTELUS GRISEUS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (HEMOGLOBIN); COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: ALPHA CHAIN; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROTEIN (HEMOGLOBIN); COMPND 7 CHAIN: B, D; COMPND 8 FRAGMENT: BETA CHAIN
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUSTELUS GRISEUS; SOURCE 3 ORGANISM_TAXID: 89020; SOURCE 4 TISSUE: BLOOD; SOURCE 5 CELL: RED BLOOD CELL; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUSTELUS GRISEUS; SOURCE 8 ORGANISM_TAXID: 89020; SOURCE 9 TISSUE: BLOOD; SOURCE 10 CELL: RED BLOOD CELL
KEYWDS HEMOGLOBIN, CARBON MONOXIDE BOUND FORM, OXYGEN KEYWDS 2 STORAGE/TRANSPORT COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.NAOI,K.T.CHONG,K.YOSHIMATSU,G.MIYAZAKI,J.R.H.TAME, AUTHOR 2 S.Y.PARK,S.I.ADACHI,H.MORIMOTO
REVDAT 5 24-FEB-09 1GCW 1 VERSN REVDAT 4 01-APR-03 1GCW 1 JRNL REVDAT 3 28-JAN-03 1GCW 1 REMARK REVDAT 2 11-APR-01 1GCW 1 JRNL REVDAT 1 06-SEP-00 1GCW 0
JRNL AUTH Y.NAOI,K.T.CHONG,K.YOSHIMATSU,G.MIYAZAKI,J.R.TAME, JRNL AUTH 2 S.Y.PARK,S.ADACHI,H.MORIMOTO JRNL TITL THE FUNCTIONAL SIMILARITY AND STRUCTURAL DIVERSITY JRNL TITL 2 OF HUMAN AND CARTILAGINOUS FISH HEMOGLOBINS. JRNL REF J.MOL.BIOL. V. 307 259 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11243818 JRNL DOI 10.1006/JMBI.2000.4446
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 37342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1963 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4268 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1GCW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-AUG-00. REMARK 100 THE RCSB ID CODE IS RCSB005039.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-18B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : FUJI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 255405 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.5 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.26500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG2000, SODIUM PHOSPHATE, HYDRO REMARK 280 SULFIDE, PH 7.00, SMALL TUBES, TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.35000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.41500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.22500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.41500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.35000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.22500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 44 REMARK 465 ARG B 45 REMARK 465 THR B 46 REMARK 465 ASP B 47 REMARK 465 GLN B 134 REMARK 465 TYR B 135 REMARK 465 LYS D 44 REMARK 465 ARG D 45 REMARK 465 THR D 46 REMARK 465 ASP D 47 REMARK 465 GLN D 134 REMARK 465 TYR D 135
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 58 CG HIS A 58 CD2 0.059 REMARK 500 HIS B 82 CG HIS B 82 CD2 0.063 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 90 -72.61 -68.80 REMARK 500 HIS B 2 109.12 73.06 REMARK 500 TYR B 35 75.16 -117.28 REMARK 500 ASP B 69 20.18 -73.03 REMARK 500 ASP B 70 55.54 -172.79 REMARK 500 LYS B 76 -77.02 -41.16 REMARK 500 ALA B 83 -80.80 -92.62 REMARK 500 ASP B 85 -58.37 -161.30 REMARK 500 LYS B 109 -126.40 41.22 REMARK 500 PRO C 37 -39.46 -38.45 REMARK 500 ASP C 75 50.35 -145.70 REMARK 500 HIS D 67 39.87 -141.51 REMARK 500 LEU D 107 -72.33 -63.12 REMARK 500 LYS D 109 -130.38 46.45 REMARK 500 PHE D 112 65.41 -106.34 REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 141 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 87 NE2 REMARK 620 2 CMO A 142 C 173.3 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 136 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 82 NE2 REMARK 620 2 CMO B 137 C 176.1 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 141 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 87 NE2 REMARK 620 2 CMO C 142 C 176.8 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 136 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 82 NE2 REMARK 620 2 CMO D 137 C 177.8 REMARK 620 N 1
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 141 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMO A 142 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 136 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMO B 137 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM C 141 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMO C 142 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 136 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CMO D 137
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GCV RELATED DB: PDB REMARK 900 1GCV CONTAINS THE DEOXY FORM OF HEMOGLOBIN.
DBREF 1GCW A 1 140 UNP Q9YGW2 HBA_MUSGR 1 140 DBREF 1GCW B 1 135 UNP Q9YGW1 HBB_MUSGR 2 136 DBREF 1GCW C 1 140 UNP Q9YGW2 HBA_MUSGR 1 140 DBREF 1GCW D 1 135 UNP Q9YGW1 HBB_MUSGR 2 136
SEQRES 1 A 140 ALA PHE THR ALA CYS GLU LYS GLN THR ILE GLY LYS ILE SEQRES 2 A 140 ALA GLN VAL LEU ALA LYS SER PRO GLU ALA TYR GLY ALA SEQRES 3 A 140 GLU CYS LEU ALA ARG LEU PHE VAL THR HIS PRO GLY SER SEQRES 4 A 140 LYS SER TYR PHE GLU TYR LYS ASP TYR SER ALA ALA GLY SEQRES 5 A 140 ALA LYS VAL GLN VAL HIS GLY GLY LYS VAL ILE ARG ALA SEQRES 6 A 140 VAL VAL LYS ALA ALA GLU HIS VAL ASP ASP LEU HIS SER SEQRES 7 A 140 HIS LEU GLU THR LEU ALA LEU THR HIS GLY LYS LYS LEU SEQRES 8 A 140 LEU VAL ASP PRO GLN ASN PHE PRO MET LEU SER GLU CYS SEQRES 9 A 140 ILE ILE VAL THR LEU ALA THR HIS LEU THR GLU PHE SER SEQRES 10 A 140 PRO ASP THR HIS CYS ALA VAL ASP LYS LEU LEU SER ALA SEQRES 11 A 140 ILE CYS GLN GLU LEU SER SER ARG TYR ARG SEQRES 1 B 135 VAL HIS TRP THR GLN GLU GLU ARG ASP GLU ILE SER LYS SEQRES 2 B 135 THR PHE GLN GLY THR ASP MET LYS THR VAL VAL THR GLN SEQRES 3 B 135 ALA LEU ASP ARG MET PHE LYS VAL TYR PRO TRP THR ASN SEQRES 4 B 135 ARG TYR PHE GLN LYS ARG THR ASP PHE ARG SER SER ILE SEQRES 5 B 135 HIS ALA GLY ILE VAL VAL GLY ALA LEU GLN ASP ALA VAL SEQRES 6 B 135 LYS HIS MET ASP ASP VAL LYS THR LEU PHE LYS ASP LEU SEQRES 7 B 135 SER LYS LYS HIS ALA ASP ASP LEU HIS VAL ASP PRO GLY SEQRES 8 B 135 SER PHE HIS LEU LEU THR ASP CYS ILE ILE VAL GLU LEU SEQRES 9 B 135 ALA TYR LEU ARG LYS ASP CYS PHE THR PRO HIS ILE GLN SEQRES 10 B 135 GLY ILE TRP ASP LYS PHE PHE GLU VAL VAL ILE ASP ALA SEQRES 11 B 135 ILE SER LYS GLN TYR SEQRES 1 C 140 ALA PHE THR ALA CYS GLU LYS GLN THR ILE GLY LYS ILE SEQRES 2 C 140 ALA GLN VAL LEU ALA LYS SER PRO GLU ALA TYR GLY ALA SEQRES 3 C 140 GLU CYS LEU ALA ARG LEU PHE VAL THR HIS PRO GLY SER SEQRES 4 C 140 LYS SER TYR PHE GLU TYR LYS ASP TYR SER ALA ALA GLY SEQRES 5 C 140 ALA LYS VAL GLN VAL HIS GLY GLY LYS VAL ILE ARG ALA SEQRES 6 C 140 VAL VAL LYS ALA ALA GLU HIS VAL ASP ASP LEU HIS SER SEQRES 7 C 140 HIS LEU GLU THR LEU ALA LEU THR HIS GLY LYS LYS LEU SEQRES 8 C 140 LEU VAL ASP PRO GLN ASN PHE PRO MET LEU SER GLU CYS SEQRES 9 C 140 ILE ILE VAL THR LEU ALA THR HIS LEU THR GLU PHE SER SEQRES 10 C 140 PRO ASP THR HIS CYS ALA VAL ASP LYS LEU LEU SER ALA SEQRES 11 C 140 ILE CYS GLN GLU LEU SER SER ARG TYR ARG SEQRES 1 D 135 VAL HIS TRP THR GLN GLU GLU ARG ASP GLU ILE SER LYS SEQRES 2 D 135 THR PHE GLN GLY THR ASP MET LYS THR VAL VAL THR GLN SEQRES 3 D 135 ALA LEU ASP ARG MET PHE LYS VAL TYR PRO TRP THR ASN SEQRES 4 D 135 ARG TYR PHE GLN LYS ARG THR ASP PHE ARG SER SER ILE SEQRES 5 D 135 HIS ALA GLY ILE VAL VAL GLY ALA LEU GLN ASP ALA VAL SEQRES 6 D 135 LYS HIS MET ASP ASP VAL LYS THR LEU PHE LYS ASP LEU SEQRES 7 D 135 SER LYS LYS HIS ALA ASP ASP LEU HIS VAL ASP PRO GLY SEQRES 8 D 135 SER PHE HIS LEU LEU THR ASP CYS ILE ILE VAL GLU LEU SEQRES 9 D 135 ALA TYR LEU ARG LYS ASP CYS PHE THR PRO HIS ILE GLN SEQRES 10 D 135 GLY ILE TRP ASP LYS PHE PHE GLU VAL VAL ILE ASP ALA SEQRES 11 D 135 ILE SER LYS GLN TYR
HET HEM A 141 43 HET CMO A 142 2 HET HEM B 136 43 HET CMO B 137 2 HET HEM C 141 43 HET CMO C 142 2 HET HEM D 136 43 HET CMO D 137 2
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CMO CARBON MONOXIDE
HETSYN HEM HEME
FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 6 CMO 4(C O) FORMUL 13 HOH *63(H2 O)
HELIX 1 1 CYS A 5 SER A 20 1 16 HELIX 2 2 SER A 20 HIS A 36 1 17 HELIX 3 3 PRO A 37 PHE A 43 5 7 HELIX 4 4 GLY A 52 GLU A 71 1 20 HELIX 5 5 HIS A 72 ASP A 74 5 3 HELIX 6 6 ASP A 75 LEU A 80 1 6 HELIX 7 7 LEU A 80 LYS A 89 1 10 HELIX 8 8 GLN A 96 LEU A 113 1 18 HELIX 9 9 SER A 117 LEU A 135 1 19 HELIX 10 10 THR B 4 THR B 18 1 15 HELIX 11 11 ASP B 19 TYR B 35 1 17 HELIX 12 12 PRO B 36 GLN B 43 5 8 HELIX 13 13 ARG B 49 HIS B 67 1 19 HELIX 14 14 ASP B 70 PHE B 75 1 6 HELIX 15 15 PHE B 75 ASP B 84 1 10 HELIX 16 16 ASP B 89 GLY B 91 5 3 HELIX 17 17 SER B 92 LYS B 109 1 18 HELIX 18 18 ASP B 110 PHE B 112 5 3 HELIX 19 19 THR B 113 SER B 132 1 20 HELIX 20 20 THR C 3 SER C 20 1 18 HELIX 21 21 SER C 20 HIS C 36 1 17 HELIX 22 22 PRO C 37 PHE C 43 5 7 HELIX 23 23 GLY C 52 GLU C 71 1 20 HELIX 24 24 HIS C 72 ASP C 74 5 3 HELIX 25 25 ASP C 75 LEU C 80 1 6 HELIX 26 26 LEU C 80 GLY C 88 1 9 HELIX 27 27 GLN C 96 LEU C 113 1 18 HELIX 28 28 SER C 117 SER C 136 1 20 HELIX 29 29 THR D 4 THR D 18 1 15 HELIX 30 30 ASP D 19 TYR D 35 1 17 HELIX 31 31 PRO D 36 GLN D 43 5 8 HELIX 32 32 ARG D 49 HIS D 67 1 19 HELIX 33 33 ASP D 70 PHE D 75 1 6 HELIX 34 34 PHE D 75 ASP D 85 1 11 HELIX 35 35 SER D 92 ARG D 108 1 17 HELIX 36 36 LYS D 109 PHE D 112 5 4 HELIX 37 37 THR D 113 ALA D 130 1 18
LINK NE2 HIS A 87 FE HEM A 141 1555 1555 2.22 LINK NE2 HIS B 82 FE HEM B 136 1555 1555 2.26 LINK NE2 HIS C 87 FE HEM C 141 1555 1555 2.09 LINK NE2 HIS D 82 FE HEM D 136 1555 1555 2.28 LINK FE HEM A 141 C CMO A 142 1555 1555 1.92 LINK FE HEM B 136 C CMO B 137 1555 1555 1.87 LINK FE HEM C 141 C CMO C 142 1555 1555 1.91 LINK FE HEM D 136 C CMO D 137 1555 1555 1.91
SITE 1 AC1 14 TYR A 42 PHE A 43 HIS A 58 LYS A 61 SITE 2 AC1 14 ALA A 65 HIS A 87 LEU A 91 ASN A 97 SITE 3 AC1 14 PHE A 98 LEU A 101 CYS A 132 LEU A 135 SITE 4 AC1 14 CMO A 142 LYS B 13 SITE 1 AC2 3 HIS A 58 VAL A 62 HEM A 141 SITE 1 AC3 12 MET B 31 TYR B 41 PHE B 42 HIS B 53 SITE 2 AC3 12 LEU B 78 HIS B 82 LEU B 86 VAL B 88 SITE 3 AC3 12 SER B 92 PHE B 93 ILE B 131 CMO B 137 SITE 1 AC4 3 HIS B 53 VAL B 57 HEM B 136 SITE 1 AC5 12 TYR C 42 PHE C 43 HIS C 58 LEU C 83 SITE 2 AC5 12 HIS C 87 LEU C 91 ASN C 97 PHE C 98 SITE 3 AC5 12 LEU C 101 LEU C 135 CMO C 142 HOH C1055 SITE 1 AC6 3 HIS C 58 VAL C 62 HEM C 141 SITE 1 AC7 11 TYR D 41 PHE D 42 HIS D 53 ILE D 56 SITE 2 AC7 11 LYS D 81 HIS D 82 SER D 92 PHE D 93 SITE 3 AC7 11 LEU D 96 ILE D 131 CMO D 137 SITE 1 AC8 3 HIS D 53 VAL D 57 HEM D 136
CRYST1 66.700 80.450 114.830 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014993 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012430 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008709 0.00000